| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |